Clinical Lymphoma, Myeloma and Leukemia

SJR Rank #9,568H-index: 71SJR: 0.615Best quartile: Q2APC: US$3,890
Journal website: aims, scope and author guidelines
Publisher

Elsevier Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • HematologyQ2
  • Cancer ResearchQ3
  • OncologyQ3

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchMyeloproliferative Neoplasms: Diagnosis and TreatmentCAR-T cell therapy researchProtein Degradation and InhibitorsCancer Treatment and Pharmacology

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03006009001200

Documents per Year

202220250200400600800

Detailed Information

ISSN

2152-2650, 2152-2669

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

2.70

References per Document

41.39

Coverage

2010-2026

Scope

Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

Metrics from SCImago Journal Rank 2025. View on SCImago